ArticleFrontiers in medicine2026
Cesarean delivery in a patient with inclusion body myositis: is general anesthesia safe? A case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inclusion body myositis (IBM) is a rare inflammatory myopathy characterized by progressive limb muscle weakness, dysphagia, and respiratory impairment. In this report, we review the case of a pregnant patient with IBM who underwent cesarean section safely under general anesthesia. Perioperative anesthetic management for these patients has been rarely described. Case presentation: We describe a 43-year-old parturient (G2P1) who was diagnosed with IBM 7 years prior to this pregnancy, with confirmed involvement of the flexor digitorum profundus and quadriceps muscles. She had mild dysphagia but no respiratory muscle involvement. Due to gestational diabetes mellitus and fetal macrosomia, she required a cesarean section. General anesthesia was administered with aspiration precautions and prophylaxis against malignant hyperthermia (MH). General anesthesia, combined with a reduced dose of rocuronium and reversal with sugammadex, facilitated uneventful extubation within 30 min postoperatively. The newborn was assigned a 10/10 Apgar score at 1 and 5 min after delivery, and the patient was discharged on postoperative day 4 without complications. Conclusion: This case demonstrates that, with precautionary preparations targeting potential complications-including aspiration risk, MH, exaggerated sensitivity to neuromuscular blocking agents (NMBAs), and postoperative pulmonary complications-general anesthesia may be a safe and feasible option for cesarean delivery in IBM patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.